Clinical trial
A Study to Evaluate the Safety and Efficacy of Clozapine in Patients With…
NCT00250575 · Novartis, Industry · Completed
Key facts
| NCT number | NCT00250575 |
|---|---|
| Title | A Study to Evaluate the Safety and Efficacy of Clozapine in Patients With Treatment-resistant Schizophrenia |
| Official title | A 24-week, Multicenter, Open-label Study to Evaluate the Safety and Efficacy of Clozapine in Patients With Treatment-resistant Schizophrenia |
| Lead sponsor | Novartis, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Schizophrenia |
| Intervention type | Drug |
| Interventions | Clozapine |
| Enrollment | 43 |
| Start date | Nov 1, 2005 |
| Primary completion | Dec 1, 2009 |
| First posted | Nov 8, 2005 |
| Last update posted | Apr 21, 2016 |
| Countries | Japan |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: